0001213900-21-017861.txt : 20210326 0001213900-21-017861.hdr.sgml : 20210326 20210326060158 ACCESSION NUMBER: 0001213900-21-017861 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210326 DATE AS OF CHANGE: 20210326 EFFECTIVENESS DATE: 20210326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADIAL PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001513525 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 800667150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-393625 FILM NUMBER: 21774551 BUSINESS ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 BUSINESS PHONE: 434-422-9800 MAIL ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 FORMER COMPANY: FORMER CONFORMED NAME: ADial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20170515 FORMER COMPANY: FORMER CONFORMED NAME: Adial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20110218 D 1 primary_doc.xml X0708 D LIVE 0001513525 ADIAL PHARMACEUTICALS, INC. 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA VIRGINIA 22901 (434) 422-9800 DELAWARE Adial Pharmaceuticals L.L.C. ADial Pharmaceuticals, L.L.C. Adial Pharmaceuticals, L.L.C. Corporation true 2017 William B. Stilley, III 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22902 Executive Officer Director Joseph M. Truluck 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Executive Officer James K. Anderson 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Robertson H. Gilliland 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director James W. Newman, Jr. 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Kevin Schuyler 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Tony Goodman 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Pharmaceuticals Decline to Disclose 06b false 2021-03-11 false true false 0 2100003 291003 1809000 false 5 0 0 0 true While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false ADIAL PHARMACEUTICALS, INC. /s/ William B. Stilley, III William B. Stilley, III Chief Executive Officer 2021-03-25